Navigation Links
BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010

ARLINGTON, Va., Dec. 1 /PRNewswire/ -- BioInformatics, LLC announces the release of its newest report, The Market Outlook for Research Products in FY2010. The 8.2 billion dollars appropriated to the NIH Scientific Research program by the American Recovery and Reinvestment Act (ARRA) is being earmarked for lab renovations, Challenge Grants, the Shared Instrumentation Program and research that spans multiple public and non-profit institutions, all of which will have an immediate and long-term impact on the life science tools industry. Comprised of responses from scientists with varying degrees of influence and purchasing authority in the lab, The Market Outlook for Research Products in FY2010 was designed to help provide insight as to how labs are going to allocate their budgets over the next fiscal year, how they are responding to the economic recession and where they believe their organizations are headed in FY2011.

Researchers predict that their FY2010 budgets will, on average, be 4.5% higher than their budgets for FY2009. On the whole, academic respondents foresee slightly larger budget increases (5.5%), while industrial respondents expect somewhat smaller budget increases.

The Market Outlook for Research Products in FY2010, includes detailed responses from nearly 800 scientists about their FY2010 budgets, planned expenditures and sources of funding. This study compares and contrasts FY2009 (actual) and FY2010 (projected) budgets in total, and by product category with a special focus on market segment and regional differences. European and U.S. scientists are asked about planned purchases of both consumables and instrumentation, and from what sources they expect to receive funding, with an emphasis on the ARRA. 61% of the survey respondents said that either they or someone in their lab applied for a recovery act grant.

In this report, scientists also indicate planned instrument and consumable purchases by vendor. The following suppliers were provided as some of the choices in the survey:

Abcam (LSE: ABC.L)

Abgene (Thermo Fisher Scientific ( TMO))

Affymetrix (NasdaqGS: AFFX)

Agilent Technologies

BD Biosciences ( BDX)

Bio-Rad ( BIO)

Beckman Coulter ( BEC)

BioSource (Life Technologies (NasdaqGS: LIFE))


Millipore ( MIL)

GE Healthcare (Amersham) ( GE)


Leica Microsystems

PerkinElmer ( PKI)

Qiagen (NasdaqGS: QGEN)

Roche Applied Science

Sigma-Aldrich ( SIAL)

Waters Corporation

"While the overall projections for growth in researchers' FY2010 research budgets are generally positive, differences by geographic region and market segment with respect to funding sources and budget realities will impact not only the spending practices of various labs, but also their receptivity to life science suppliers and their marketing and advertising campaigns," states Tamara Zemlo, Ph.D., MPH, Vice President of Advisory Services. Dr. Zemlo further notes that "Suppliers that are sensitive to a researcher's perceptions of the economy and how it is affecting their science are more likely to maintain good customer relations if they offer promotions that specifically address their customers' concerns."

To learn more about this report, a complimentary Executive Summary is available at


BioInformatics, LLC is the premier research and advisory firm serving the life science industry. By leveraging our professional social network of more than 45,000 biomedical researchers, we have supported more than 300 companies and provided insights that lead to better business decisions. Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information contact:
Mary Follin
Manager, Marketing/Sales
BioInformatics, LLC
2111 Wilson Blvd., Suite 250
Arlington, VA  22201
703.778.3080 x13 (phone)

SOURCE BioInformatics, LLC

SOURCE BioInformatics, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
2. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
3. Reportlinker Adds Operating Tables - A World Market Review
4. Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report
5. Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015
6. Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014)
7. Reportlinker Adds Surgical Incision Closures - Global Trends
8. Reportlinker Adds Decubitus Ulcer Treatment Products - A Worldwide Market Review
9. Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective
10. Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response
11. Pharmasset Reports Fiscal Year End 2009 Financial Results
Post Your Comments:
(Date:11/25/2015)... AVIV, Israel , November 25, 2015 ... (NASDAQ: KTOV ) (TASE: KTOV), a biopharmaceutical company ... simultaneous treatment of various clinical conditions, today announced the ... 3,158,900 American Depository Shares ( ADSs ), each representing ... purchase up to 3,158,900 ADSs. The ADSs and warrants ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: ... and Rugen Therapeutics, a start-up  biotechnology company focused ... CNS disorders and funded by the F-Prime Biomedical ... entered into an exclusive collaboration to support the ... Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... TEL AVIV, Israel , November 25, 2015 /PRNewswire/ ... firms (the "New Investors"), pursuant to which BioLight and ... in BioLight,s IOPtima Ltd. subsidiary ("IOPtima") via a private ... global commercialization of its innovative IOPtimate™ system used in ... a regulatory approval pathway process for the IOPtimate™ system ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast cancers found ... mammography, according to a study published online in the journal Radiology. Researchers said ... may necessitate a change in treatment. , Breast MRI is the most sensitive ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, one of ... its stellar workplace culture with the company’s Cincinnati office being named a finalist ... office was named a finalist in Cincinnati Business Courier’s 13th annual Greater Cincinnati ...
(Date:11/25/2015)... ... , ... On November 10, 2015, Bohrer Brady, LLC filed a class and ... a home health care worker who provided companionship services for the elderly, ill or ... by Humana, Inc., Humana at Home, Inc., and SeniorBridge Family Companies (CT), Inc. since ...
(Date:11/25/2015)... ... , ... Dental professionals who would like to become more proficient on their ... Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held on December ... of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud to announce ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... On November ... of Tri Lite’s personal heating products business. Cozy Products explains what this ... heaters that fit in well with the Cozy Products business model: to sell personal ...
Breaking Medicine News(10 mins):